• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Professional Introduction to Compound with CAS No. 1144044-68-7 and Product Name (1-methyl-1H-indazol-4-yl)methanamine

Compound with the CAS number 1144044-68-7 and the product name (1-methyl-1H-indazol-4-yl)methanamine represents a significant area of interest in the field of chemical biology and pharmaceutical research. This compound, belonging to the indazole derivatives class, has garnered attention due to its unique structural properties and potential biological activities. Indazole derivatives are known for their diverse pharmacological effects, making them valuable candidates for further exploration in drug development.

The molecular structure of (1-methyl-1H-indazol-4-yl)methanamine consists of a benzene ring fused with a pyrrole ring, with a methyl group attached to the nitrogen atom of the pyrrole ring and an amine group at the 4-position of the benzene ring. This particular arrangement imparts distinct chemical and biological characteristics to the compound, which have been the focus of numerous studies in recent years.

In recent years, there has been a surge in research aimed at identifying novel bioactive compounds that can modulate various biological pathways. Among these, indazole derivatives have shown promise due to their ability to interact with multiple targets within cellular systems. The presence of both aromatic and heterocyclic rings in (1-methyl-1H-indazol-4-yl)methanamine allows for versatile interactions with biological molecules, including enzymes and receptors.

One of the most compelling aspects of this compound is its potential as an intermediate in the synthesis of more complex molecules. The amine functional group at the 4-position provides a reactive site for further chemical modifications, enabling the development of novel derivatives with enhanced pharmacological properties. This flexibility has made (1-methyl-1H-indazol-4-yl)methanamine a valuable building block in synthetic chemistry.

The pharmacological profile of indazole derivatives has been extensively studied, particularly in the context of their antimicrobial, anti-inflammatory, and anticancer properties. For instance, certain indazole compounds have demonstrated efficacy in inhibiting the growth of various cancer cell lines by targeting key signaling pathways involved in cell proliferation and survival. While (1-methyl-1H-indazol-4-yl)methanamine itself may not exhibit direct therapeutic effects, its structural features suggest that it could serve as a precursor for drugs targeting similar pathways.

Recent advancements in computational chemistry have enabled researchers to predict the biological activity of compounds with high accuracy before conducting expensive experimental trials. Molecular docking studies have been particularly useful in understanding how (1-methyl-1H-indazol-4-yl)methanamine interacts with potential target proteins. These studies have revealed that the compound can bind to various enzymes and receptors, suggesting multiple avenues for therapeutic intervention.

In addition to its potential as a drug intermediate, (1-methyl-1H-indazol-4-yl)methanamine has also been explored as a ligand in biochemical assays. Its ability to bind to specific biomolecules makes it useful for developing probes that can help researchers understand complex biological processes at a molecular level. This application is particularly relevant in fields such as drug discovery and toxicology, where understanding molecular interactions is crucial.

The synthesis of indazole derivatives like (1-methyl-1H-indazol-4-yl)methanamine has been optimized through various methodologies over the years. Modern synthetic approaches often emphasize green chemistry principles, aiming to minimize waste and improve efficiency. Catalytic methods, for example, have enabled more sustainable production processes while maintaining high yields and purity levels.

The future prospects for research on compounds like (1-methyl-1H-indazol-4-yl)methanamine are promising. As our understanding of biological systems continues to grow, so does the need for innovative tools to study these systems at a molecular level. Indazole derivatives offer a rich structural framework that can be exploited to develop new therapeutics and research tools.

In conclusion, compound with CAS No. 1144044-68-7 and product name (1-methyl-1H-indazol-4-ylyl)methanamine represents a significant area of interest in chemical biology and pharmaceutical research. Its unique structural features and potential biological activities make it a valuable candidate for further exploration. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in drug development and biochemical studies.

• 267413-31-0(1-Methyl-1H-indazole-6-methanamine)
• 1357945-57-3((1-Methyl-1h-Indazol-6-yl)methanamine Hydrochloric Acid Salt)
• 267413-27-4((1-methyl-1H-indazol-5-yl)methanamine)
• 1234616-52-4((2,3-dimethyl-2H-indazol-6-yl)methanamine)
• 1159511-35-9(1-(1-methyl-1H-indazol-5-yl)ethan-1-amine)
• 34879-87-3(1H-Indazole, 1,6-dimethyl-)
• 1334405-46-7((1-methyl-1H-indazol-4-yl)methanamine hydrochloride)
• 1159511-56-4(6-(2-Aminoethyl)-1-methyl-1H-indazole)
• 1159511-63-3((2-Methyl-2H-indazol-5-yl)methanamine)
• 1144044-67-6((2-methyl-2H-indazol-7-yl)methanamine)